Itraconazole
Edina Avdic, Pharm.D.
Pediatric Dosing Author:
Lisa Hutchins, Pharm.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Following fungal infections in immunocompromised and non-immunocompromised patients:
Aspergillosis
: treatment-intolerant of or refractory to
amphotericin B
therapy
Pulmonary and extrapulmonary
blastomycosis
Histoplasmosis
, including chronic cavitary pulmonary disease and disseminated non-meningeal histoplasmosis
Onychomycosis
in non-immunocompromised patients (oral capsule):
Onychomycosis of the toenail, with or without fingernail involvement, due to
dermatophytes
(tinea unguium)
Onychomycosis of the fingernail due to dermatophytes (tinea unguium).
Oropharyngeal
and esophageal candidiasis (oral liquid)
Neutropenic fever
in patients with suspected fungal infection (oral liquid).
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Coccidioidomycosis
Cryptococcosis
(
fluconazole
preferred)
Penicilliosis
Sporotrichosis
Candida vaginitis
Fluconazole
-resistant
esophageal candidiasis
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2024 Unbound Medicine, Inc. All rights reserved